PHEMI a Gartner Cool Vendor in Healthcare Providers

VANCOUVER, British Columbia–(BUSINESS WIRE)–PHEMI, the company delivering big data solutions with built-in privacy, governance, and enterprise-grade management, says its status as a Gartner Cool Vendor for Healthcare Providers is based upon a big data warehouse solution that meets the complex challenges associated with precision medicine and clinical research initiatives. Gartner’s Cool Vendors research was initiated to help CIOs and other top IT leaders stay ahead of the IT technology curve, while making better strategic decisions about technology and services.

.@PHEMI selected Gartner Cool Vendor Healthcare Providers, meets complex #PrecisionMed, clinical research challenges

Tweet this

In November 2016, PHEMI introduced the PHEMI Central Precision Medicine Edition, a big data management system for genotypic and phenotypic information that’s purpose-built for privacy, performance, and governance. The PHEMI Central Precision Medicine Edition is a sister product to PHEMI Central, a big data warehouse platform that solves the challenge of healthcare data integration and governance, expediting the ability to work with large data sets and collaborate more confidentially and effectively. Because PHEMI decreases the work of ingesting and governing data, attention can be focused on deriving value and insights from data.

According to Gartner, “CIOs, CMOs, chief data officers (CDOs), lead researchers and data architects responsible for architecting advanced analytic environments, and who work with complex and rich data sources, should consider platforms that decrease the work on the ingestion and governance side so that attention can be focused on deriving value from the data.”¹

“It’s rewarding to receive recognition through Gartner’s Cool Vendor research for our efforts to offer the most advanced and comprehensive big data solutions for healthcare analytics. PHEMI is helping organizations deliver on the promise of big data today, while providing a platform that can scale to meet future needs,” said Paul Terry, CEO, PHEMI. “Because of these capabilities, we’re also seeing massive interest from other sectors, like insurance, finance and the public sector, markets where sensitive data needs to be used responsibly to help transform their businesses.”

PHEMI Central Precision Medicine Edition provides interactive performance across the entire genotype and phenotype at scale, independent of the amount and types of data in the system. Powerful data governance management features address the privacy and security challenges related to healthcare, enabling the sharing of data across researchers, providers and other collaborators.

Gartner clients or subscribers can discover more Details about PHEMI’s status as a Cool Vendor by visiting the Gartner website to read the full report.

¹ Gartner, Cool Vendors in Healthcare Providers, 2017, 24 April 2017

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About PHEMI
PHEMI delivers privacy, security, governance and enterprise-grade management for big data. Its flagship product, PHEMI Central Big Data Warehouse, embeds privacy policies and enforces access privileges, and data sharing agreements at the data level, removing a critical roadblock standing in the way of enterprises that aim to become data-driven.

PHEMI Central lets organizations easily access and mine any variety of data at any volume to drive insights that lower costs, improve outcomes, and allow better decisions faster. PHEMI brings both privacy and performance to big data. For more information visit https://www.phemi.com/ and follow us on Twitter.